Research

- 08.032026
  
  Stricter Pharmaceutical Regulation: Analysis of Four Core Compliance Priorities in the 2026 Key Work Points on Rectifying Improper Practices
  
  see more
- 07.312026
  
  From a 3.6-billion-yuan Fine to Nine Years in Prison: The Criminal Net for Insider Trading Tightens Further
  
  see more
- 07.282026
  
  Walk the Right Path Together | Lawyer Xia Weifeng: Breaking Boundaries to Forge New Paths, Cultivating Intellectual Property Legal Services with Long-termism
  
  see more
- 07.222026
  
  Practical Compliance Series for Pharmaceutical & Healthcare Advertisements (IV): Special Regulatory Restrictions in the Industry — A Comprehensive Analysis from Efficacy Claims and Endorsement Bans to Distribution Channels
  
  see more
- 07.202026
  
  LVMH v. Molly White Case: Typological Analysis of the Likelihood of Confusion Among Distinct Consumer Groups
  
  see more
- 07.162026
  
  Series 2 of Wealth Inheritance and Pitfall‑Avoidance: Chapter 1 Nine Essential Traits of Fraud (Points 7‑9)
  
  see more